Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
4.130
-0.160 (-3.73%)
At close: Mar 3, 2026, 4:00 PM EST
4.300
+0.170 (4.12%)
Pre-market: Mar 4, 2026, 8:11 AM EST
Evolus Market Cap
Evolus has a market cap or net worth of $268.7 million as of March 4, 2026. Its market cap has decreased by -71.21% in one year.
Market Cap
268.70M
Enterprise Value
369.87M
1-Year Change
-71.21%
Ranking
Category
Stock Price
$4.13
Market Cap Chart
Since February 8, 2018, Evolus's market cap has decreased from $271.30M to $268.70M, a decrease of -0.96%. That is a compound annual growth rate of -0.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 268.70M | -37.67% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emergent BioSolutions | 461.80M |
| SIGA Technologies | 445.42M |
| Canopy Growth | 403.25M |
| Organogenesis Holdings | 369.20M |
| Akebia Therapeutics | 326.81M |
| Lifecore Biomedical | 261.89M |
| Journey Medical | 259.73M |
| Anika Therapeutics | 207.67M |